Corleen M. Roche's most recent trade in Iovance Biotherapeutics Inc was a trade of 300,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Iovance Biotherapeutics Inc | Corleen M. Roche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2025 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| Iovance Biotherapeutics Inc | Corleen M. Roche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2025 | 150,000 | 150,000 | - | - | Restricted Stock Units | |
| Cg Oncology Inc | Corleen M. Roche | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 143,907 | 143,907 | - | - | Employee Stock Option (Right to Buy) | |
| Cg Oncology Inc | Corleen M. Roche | CFO | 04 Oct 2024 | 93,600 | 93,600 | - | - | Stock Option (Right to Buy) | ||
| Cg Oncology Inc | Corleen M. Roche | CFO & Secretary | 29 Jan 2024 | 2,000 | 2,000 | - | 19 | 38,000 | Common Stock | |
| Cg Oncology Inc | Corleen M. Roche | CFO & Secretary | 24 Jan 2024 | 492,920 | 492,920 | - | - | Stock Option | ||
| Immunome Inc | Corleen M. Roche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 58,000 | 58,000 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Corleen M. Roche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Corleen M. Roche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 16,609 | 16,609 | - | - | Stock Option (Right to Buy) | |
| Immunome Inc | Corleen M. Roche | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Apr 2021 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) |